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ABSTRACT
Five different types of point mutation of the ,6-amyloid precursor gene (APP) have been
reported to cosegregate with familial Alzheimer’s disease (FAD) in each of examined
pedigrees (Table 1). Here we report a screening result of the APP gene mutations in two
Japanese pedigrees with FAD of an early onset type which have previously been reported
(2, 3). Primer pairs corresponding respectively to each of 19 exons of the APP gene were
designed. Polymerase chain reaction-single strand conformation polymorphism (PCR-
SSCP) analysis was performed on genomic DNA of one affected member from each of these
two pedigrees. In addition, a pair of primers was designed to assess specifically codon 717 of
the APP gene even in the poorly-preserved sample of genomic DNA. PCR-SSCP analysis of
all 19 exons of the APP gene of both patients did not show any mutations, but disclosed one
polymorphism in the intron 9. Sequencing of exons 16 and 17 of the APP gene in both
patients, where all reported pathogenic mutations are located, revealed normal sequences.
The results support that the genetic defect causing FAD is heterogeneous and that most
cases with FAD are apparently due to the gene-defect of other than the APP gene.
Alzheimer’s disease (AD) is one of the major causes
of dementia, and its progressive neurodegeneration is
characterized by the histological ﬁndings of neuro-
fibrillary tangles, extracellular amyloid plaques, and
cerebrovascular amyloid deposits in the brain (12,
29). Although the etiology of sporadic cases ofAD
is unknown, an autosomal dominant mode of in-
heritance with age-dependent penetrance has been
observed in pedigrees with familial Alzheimer’s dis-
ease (FAD) (2, 3, 10, 20, 22, 23, 30, 33). These clini-
cal data suggest that FAD is a genetic disorder
caused by a single dominant gene defect, although
the etiology of sporadic cases may be different.
In 1984, a peptide consisting of 39 to 43 amino
acid residues, designated as ,6/A4 peptide or amy-
loid ,6’-protein, was first isolated from cerebrovascu-
lar amyloid protein (4). Subsequently amyloid ,6-
protein was suggested to be produced by proteo-
lytic cleavage of a much larger precursor protein
designated as ,6-amyloid precursor protein (APP)
(11, 27). APP exists in three major isoforms of 695,
751 and 770 amino acid residues due to alternative
splicing of its mRNA (11, 13, 21, 28). The mecha-
nism of cleavage of the ,6’/A4 peptide remains
unknown. Because the gene encoding APP was
mapped to the long arm of chromosome 21, where
DNA markers with a demonstrable genetic linkage
to FAD (D21S1/S11 and D21S16) reside, APP was
considered as a possible candidate defective gene in
some FAD pedigrees (25, 27). In 1991, Goate er al.
(5) reported, for the first time, a FAD-associated
mutation at codon 717 ofAPP. The same mutation
was soon found in 3 Japanese FAD pedigrees (18,
33). By now, a total of seven different pathogenic
mutations of the APP gene have been reported as
summarized in Table 1.
In this study, we screened the APP gene muta-
tions by the method of polymerase chain reaction-
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